Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

BACKGROUND: Classical patient and tumour characteristics are the benchmark of personalised breast cancer (BC) management. Recent evidence has demonstrated that immune and molecular profiling of BC may also play an important role. Despite evidence of differences between invasive ductal (IDC) and lobu...

Descripción completa

Detalles Bibliográficos
Autores principales: Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://www.ncbi.nlm.nih.gov/pubmed/24937677
http://dx.doi.org/10.1038/bjc.2014.338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://www.ncbi.nlm.nih.gov/pubmed/24937677
http://dx.doi.org/10.1038/bjc.2014.338

Ejemplares similares